$OLED

Universal Display (OLED) Q2 2026 Earnings Call Transcript

Universal Display (UDC) discussed OLED industry demand softness and Gen 8.6 OLED manufacturing ramp. In Q2 2026, revenue fell to $152M from $172M, with material sales down to $66M. Full-year revenue is expected near the low end of $630M to $670M. Q2 gross margin was 76%.

Original reporting
Published Aug 1, 2026, 8:15 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 1, 2026, 9:10 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Universal Display (OLED) Q2 2026 Earnings Call Transcript — source image
Decision brief

The 30-second read

$OLEDNeutralMed
01

Why it matters

Universal Display’s updated outlook lowers the expected full-year revenue trajectory toward the lower end of its prior range, alongside a decline in material sales and a modest gross margin dip year over year.

02

Market read

Traders can reassess near-term revenue risk versus longer-cycle adoption and technology progress, using the quantified Q2 results and the updated full-year revenue tracking language.

03

What to watch

Royalty and license revenue increased on cumulative catch-up adjustments, which could partially offset weakness in material sales and complicate a simple demand-only interpretation.

Relevance 8/10Novelty 7/10Timing: pre-market today, Q2 2026 earnings call transcript with updated full-year outlook

Background

The transcript discusses OLED industry cycle separation, near-term demand softness, and longer-term growth drivers tied to new manufacturing generations and application expansion.

Company-level read

Ticker impact

$OLEDNeutralMedium confidence
Context

Universal Display reports Q2 2026 revenue of $152M and guides full-year revenue toward the lower end of $630M to $670M amid softer near-term demand.

Expected impact

Likely near-term downside bias versus prior expectations, with potential stabilization if investors focus on 2027 growth resumption and phosphorescent blue commercialization progress.

Evidence & confidence

The article contains specific quarterly results and a quantified full-year revenue outlook shift, but it is a transcript and the excerpt ends before full detail on margins and operating income guidance.

Market effects

OLED ecosystem demand visibility is described as limited, but Gen 8.6 OLED manufacturing ramp and new application adoption are framed as intact longer-term drivers.

Chengdu innovation center opening and Asia manufacturing investments reinforce ongoing China and Korea supply-chain buildout.

Tariff-related demand timing and smartphone component cost pressure are cited as affecting visibility across consumer electronics supply chains.

Counterpoint

Investors may overreact to near-term caution because the company emphasizes 2027 positive OLED area growth and ongoing Gen 8.6 commercialization ramps.

Key entities

  • Universal Display

    Reports Q2 2026 financials and updates full-year revenue outlook, highlighting near-term demand softness and longer-term OLED growth drivers.

  • Gen 8.6 OLED manufacturing

    Described as becoming commercial reality, with multiple suppliers commencing mass production or advancing greenfield projects.

  • Phosphorescent blue

    Presented as a key roadmap opportunity with additional technical results and potential energy-efficiency benefits.

Related articles

$OLEDMed

Universal Display Corporation Q2 2026 Earnings Call Summary

Universal Display Corp. reported Q2 2026 revenue of $152M vs $172M a year earlier and narrowed full-year guidance toward the lower end of $630M to $670M, citing weaker smartphone volumes. Management expects materials gross margins near ~60% in 2H and says OLED area growth is flat in 2026 before resuming in 2027.

$OLEDMed

Universal Display (NASDAQ:OLED) Misses Q2 Sales Targets

OLED provider Universal Display (NASDAQ: OLED) missed Wall Street’s revenue expectations in Q2 CY2026, with sales falling 11.4% year on year to $152.2 million. On the other hand, the company’s full-year revenue guidance of $650 million at the midpoint came in 0.8% above analysts’ estimates. Its GAAP profit of $1.06 per share was 2.4% above analysts’ consensus estimates. Is now the time to buy Universal Display? Find out by accessing our full research report, it’s free.

$OLEDMed

UNIVERSAL DISPLAY CORP \PA\ (OLED): Results of Operations and Financial Condition

UNIVERSAL DISPLAY CORP \PA\ (OLED) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 oled-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 Press Release Universal Display Contact: Darice Liu investor@oled.com media@oled.com +1 609-964-5123 Universal Display Corporation Announces Second Quarter 2026 Financial Results EWING, N.J. – July 30, 2026 – Universal Displa

$OLEDMed

KDB, Hana, NH Bank Extend 200 Billion Won More to LG Display

Korea Development Bank, Hana Bank, and NH NongHyup Bank will extend 200 billion won in joint low-interest loans to LG Display to support OLED investment. The banks will provide 100, 70, and 30 billion won, with rates in the low 3% range for KDB and CD+1.15% for others. With a 1.3 trillion won National Growth Fund loan, total support is 1.5 trillion won.

$GLXYMed

Galaxy Digital (GLXY) Q2 2026 Earnings Call Transcript

Galaxy Digital (GLXY) discussed its Q2 2026 results on an earnings call. It reported GAAP net loss of $85 million (loss of $0.09/share) and firm-wide adjusted EBITDA of negative $77 million. Adjusted gross profit rose to $86 million, helped by digital asset price depreciation and Helios data center progress, with Helios Phase I delivering 133 MW to CoreWeave. The company also cited $10.8B total assets and $2.7B equity.

$ANTXMed

AN2 Therapeutics Stock Climbs To 52-Week High Despite Wider Q2 Loss

AN2 Therapeutics (ANTX) reported Q2 2026 results with a wider net loss of $8.2 million, or $0.18 per share, versus $6.5 million, or $0.21 per share, in Q2 2025. R&D rose to $6.0 million from $3.2 million, while G&A fell to $2.9 million from $4.0 million. Cash was $79.9 million. The stock hit a 52-week high at $7.19.